Laurel Jordan, DO
Obstetrics & Gynecology · Ada, OKNPI 1720188493
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 73.8% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $5,180, more than ten times the $366 reported in 2019.
Across 102 payments — averaging $67.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Bayer$239
- AbbVie$225
- Organon$217
- Mayne Pharma Commercial LLC$112
- Astellas Pharma US Inc$110
- plus $891 from 21 others
What the payments were for
- Travel & lodging$1,64624%
- Food & beverage$2,18232%
- Education$3,01044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 18 | $5,044 |
| Bayer | 12 | $239 |
| AbbVie(2 entities) | 11 | $225 |
| Organon | 12 | $217 |
| Mayne Pharma Commercial LLC | 4 | $112 |
| Astellas Pharma US Inc | 5 | $110 |
| Gynesonics, Inc. | 1 | $94 |
| Hologic Sales And Service, LLC | 5 | $93 |
| Pfizer | 5 | $87 |
| Minerva Surgical, Inc | 2 | $79 |
| Merck | 4 | $67 |
| Exeltis, USA Inc. | 3 | $59 |
| Millicent US Inc | 3 | $58 |
| Sage Therapeutics, LLC | 3 | $57 |
| Smith+Nephew | 2 | $53 |
| AstraZeneca | 1 | $28 |
| Innovation Technologies Inc | 1 | $25 |
| Mission Pharmacal Company | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Meditrina | 1 | $21 |
| Agile Therapeutics, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Exact Sciences | 1 | $20 |
| Roche Diagnostics Corporation | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| La Jolla Pharmaceutical Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$3,000
- Da Vinci Surgical System$1,895
How this compares
$6,838 in reported general payments places this provider in the 85th percentile of 396 obstetrics & gynecology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 78 | $1,726 |
| Solifenacin Succinate | 15 | $787 |
| ProgesteroneProgesterone, Micronized | 33 | $769 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $256 |
| Acyclovir | 13 | $50 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Ada
- John SiegleAda$50K
- Tori OdanielOklahoma City$917K
- Kathleen MooreOklahoma City$795K
- Joseph NemcokTulsa$632K
- Jay WilliamsonTulsa$130K
- Lori HubbardTulsa$41K
- Dawn WilsonYukon$36K
- Beverly VavrickaOklahoma City$22K
- Micah RelicTulsa$20K
- Monica ReidOklahoma City$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.